Repaglinide (1mg) Voglibose (0.3mg)

Name: Repaglinide (1mg) Voglibose (0.3mg)
Brand: STERIS HEALTHCARE PRIVATE LIMITED
Price: 60.00 INR
Availability: InStock

Price 60.00 INR/ Piece

Get a Price/Quote

MOQ : 1 Piece

Repaglinide (1mg) Voglibose (0.3mg) Specification

Origin of Medicine
India

Ingredients
Repaglinide (1mg), Voglibose (0.3mg)

Physical Form
Tablets

Dosage
As per suggestion

Dosage Guidelines
As per suggestion

Suitable For
Adults

Quantity
5000 Boxes

Storage Instructions
Cool & dry place

Repaglinide (1mg) Voglibose (0.3mg) Trade Information

Minimum Order Quantity
1 Piece

Supply Ability
5000 Pieces Per Day

Delivery Time
5 Days

Sample Policy
Contact us for information regarding our sample policy

Main Domestic Market
All India

Certifications
WHO, GMP & ISO Certified

About Repaglinide (1mg) Voglibose (0.3mg)

Repaglinide and Voglibose
Rapiglinide VOG are both medications used to treat type 2 diabetes mellitus, but they work in different ways.
Repaglinide is an oral hypoglycemic medication that belongs to the class of drugs known as meglitinides. Rapiglinide VOG works by stimulating the release of insulin from the pancreas, Rapiglinide VOG helps to lower blood sugar levels after a meal. Rapiglinide VOG is taken before meals to help control postprandial (after meal) glucose spikes.
Voglibose is an alpha-glucosidase inhibitor that works by slowing down the breakdown and absorption of carbohydrates in the small intestine, leading to a slower and more gradual increase in blood sugar levels after a meal. Voglibose is taken Rapiglinide VOG meals to help control postprandial hyperglycemia.
Both medications can be used alone or in combination with other medications, such as metformin, to help control blood sugar levels in people with type 2 diabetes. Rapiglinide VOG with all medications, Rapiglinide VOG is important to follow your healthcare provider's instructions for use and to discuss any potential side effects or interactions with other medications.
Rapiglinide VOG is available in strengths of 1.0 & 0.5 mg
For further information please contact:
contact@sterispharma.com

How This Combination Works

This medication combines Repaglinide, which promotes insulin release from the pancreas, and Voglibose, which impedes the breakdown and absorption of sugars from the digestive tract. Together, they address multiple facets of blood glucose regulation, thereby providing a comprehensive approach to diabetes management for adults.

Proper Usage and Administration

Repaglinide (1mg) and Voglibose (0.3mg) tablets should be taken strictly according to your healthcare professional's recommendation. Doses are tailored to individual needs and are generally administered before meals to optimize blood sugar control. Consistency and adherence to prescribed guidelines are crucial for achieving the best results.

FAQ's of Repaglinide (1mg) Voglibose (0.3mg):

Q: How should Repaglinide and Voglibose tablets be taken for best results?

A: These tablets should be taken before meals, exactly as prescribed by your healthcare provider. Dosage and timing are essential for effective blood sugar management, so always follow your doctor's specific instructions.

Q: What benefits do Repaglinide (1mg) and Voglibose (0.3mg) tablets offer?

A: This combination helps adults with type 2 diabetes control their blood sugar levels more efficiently by stimulating insulin release and reducing glucose absorption, thus supporting overall glycemic balance.

Q: When should I take this medication during the day?

A: The medication is typically taken before each main meal to align with periods when blood sugar spikes are most likely to occur. Always consult your physician to determine your personalized dosing schedule.

Q: Where should Repaglinide and Voglibose tablets be stored?

A: Store these tablets in a cool, dry place, away from direct sunlight and high humidity, to preserve their quality and effectiveness.

Q: What process does the body undergo with this medication?

A: Upon taking the tablets, Repaglinide stimulates the pancreas to release insulin, while Voglibose acts in the intestines to delay carbohydrate absorption. This dual action controls post-meal blood sugar surges.

Q: Who are these tablets suitable for?

A: These tablets are intended for adult patients who require medical intervention to manage type 2 diabetes, under the guidance of a healthcare provider.

Tell us about your requirement